IGF-1 LR3

DRAGON PHARMA IGF-1 LR3

IGF-1 LR3, or Insulin-like Growth Factor 1 Long R3, is a highly potent growth factor that promotes muscle growth, repair, and recovery. Manufactured by Dragon Pharma, each vial contains 1 mg of IGF-1 LR3 in a 2 mL vial. Known for its extended half-life and superior anabolic properties, IGF-1 LR3 is a favorite among athletes and bodybuilders looking to boost muscle gains, improve recovery, and optimize overall performance. Its ability to stimulate muscle cell growth makes it a powerful tool in any performance-enhancing cycle.

DRUG COMPOSITION

Active substance: Insulin-like Growth Factor 1 Long R3 (1 mg per vial)
Excipients: Sterile water and preservatives for injection stability.

PHARMACEUTICAL FORM

IGF-1 LR3 is available as a lyophilized powder that must be reconstituted with bacteriostatic water for injection. It is then administered via subcutaneous or intramuscular injection.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical Group: Growth factor
ATC Code: H01AC03 (Somatropin and somatropin agonists)

PHARMACOLOGICAL PROPERTIES

IGF-1 LR3 binds to IGF-1 receptors in muscle tissues, stimulating cell proliferation and promoting muscle repair and growth. With its extended half-life of 20-30 hours, IGF-1 LR3 provides prolonged anabolic activity, allowing for greater muscle development over time. It also enhances nutrient uptake, leading to improved recovery and better overall muscle quality.

PROFILE

• Chemical name: Insulin-like Growth Factor-1 Long R3
• Chemical formula: C400H625N111O115S9
• Percentage of anabolic activity: Very high
• Percentage of androgenic activity: None
• Active half life: 20-30 hours
• Recommended dosage: 20-100 mcg per day
• Acne: Rare
• Bloating (water retention): Unlikely
• HBR: Unlikely
• Hepatic toxicity: None
• Aromatization: None

THERAPEUTICAL INDICATIONS

IGF-1 LR3 is primarily used by bodybuilders and athletes aiming to increase lean muscle mass, enhance recovery, and reduce fat. Its anabolic properties are particularly beneficial during bulking cycles and for promoting faster recovery after intense training sessions.

DOSES AND METHOD OF ADMINISTRATION

The typical dosage of IGF-1 LR3 ranges from 20 to 100 mcg per day, depending on individual goals and experience. Beginners should start with lower doses (20-50 mcg) and gradually increase. It is injected subcutaneously or intramuscularly, and it is recommended to divide the dosage into two injections (morning and post-workout) for optimal results.

CYCLE/STACKING

IGF-1 LR3 is commonly stacked with other anabolic agents and growth hormones to amplify results. Here are some examples of cycles with Dragon Pharma products:

• Bulking Cycle (8-12 weeks):

  • IGF-1 LR3: 50 mcg per day
  • Stack with Cypionat 250 (Testosterone Cypionate) 500 mg per week for significant muscle mass gains.
  • Optionally add Anadrol for the first 4 weeks to maximize strength and mass development.

• Cutting Cycle (8-12 weeks):

  • IGF-1 LR3: 30-50 mcg per day
  • Stack with Winstrol (Stanozolol) 50 mg per day to promote lean muscle retention while shedding fat.
  • Combine with Clenbuterol for accelerated fat loss and definition.

• Recomposition Cycle (8-12 weeks):

  • IGF-1 LR3: 50 mcg per day
  • Stack with Enantat 250 (Testosterone Enanthate) 300 mg per week and Anavar 50 mg per day to gain lean muscle while losing fat.

POST CYCLE THERAPY

Post Cycle Therapy (PCT) is not necessary for IGF-1 LR3 since it does not suppress natural testosterone levels. However, if used in conjunction with anabolic steroids, standard PCT protocols (Clomid, Nolvadex) should be followed to restore natural hormone production.

SIDE EFFECTS

IGF-1 LR3 is generally well-tolerated, but some users may experience mild side effects, such as injection site irritation, headaches, or nausea. In rare cases, prolonged use of high doses may lead to excessive growth of certain tissues. Always follow dosage guidelines to minimize risks.

CONTRAINDICATIONS

IGF-1 LR3 should not be used by individuals with active cancer or those with pre-existing medical conditions like diabetes or cardiovascular disorders. Pregnant or breastfeeding women should avoid IGF-1 LR3.

OVERDOSE

In the event of an overdose, excessive tissue growth, or organ enlargement could occur. Immediate medical attention should be sought if overdose symptoms arise.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Athletes should use IGF-1 LR3 responsibly to avoid potential overgrowth of non-muscle tissues. Regular medical check-ups are advised for those on extended cycles. IGF-1 LR3 should not be combined with insulin unless under medical supervision due to the potential for hypoglycemia.

INTERACTIONS WITH OTHER DRUGS

IGF-1 LR3 may interact with insulin and other glucose-lowering drugs. Consult a healthcare provider if combining with other medications that affect blood sugar levels.

PRESENTATION, PACKAGING

IGF-1 LR3 by Dragon Pharma is available in 2 mL vials containing 1 mg of lyophilized IGF-1 LR3. The packaging ensures secure and discreet delivery to ensure product safety.

STORAGE

Store IGF-1 LR3 vials in a cool, dry place, away from direct sunlight. Once reconstituted, keep refrigerated and use within 30 days. Keep out of reach of children.

DELIVERY TO THE USA

We offer fast and secure delivery of Dragon Pharma's IGF-1 LR3 to the USA. All shipments are discreetly packaged and tracked to ensure timely arrival at your doorstep.

LEGAL STATUS

IGF-1 LR3 is available for research purposes in many countries, including the USA. It is not approved for medical use by the FDA, so be sure to check your local laws and regulations before purchasing.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• IGF-1 LR3 Wiki, wikipedia.org
• IGF-1 LR3 National Library of Medicine, ncbi.nlm.nih.gov